The level of MMP-9 increases and VE-cadherin decreases as the age of patients rises, indicating later MMD onsets, higher gelatinase activity, and poorer BBB function the patients might have, which might be related with hemorrhagic stroke presentations. This evidence concerns the gene MMP9 and hemorrhagic stroke.